Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCK | P08631 | 6/20 | 0.67 |
| ▸ | SRC | P12931 | 6/20 | 0.67 |
| ▸ | ABL1 | P00519 | 4/20 | 0.67 |
| ▸ | EGFR | P00533 | 4/20 | 0.67 |
| ▸ | TEK | Q02763 | 3/20 | 0.67 |
| ▸ | LCK | P06239 | 2/20 | 0.67 |
| ▸ | RET | P07949 | 2/20 | 0.67 |
| ▸ | KDR | P35968 | 2/20 | 0.67 |
| ▸ | FLT3 | P36888 | 2/20 | 0.67 |
| ▸ | PLK4 | O00444 | 1/20 | 0.67 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.67 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.67 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.67 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.67 |
| ▸ | PAK4 | O96013 | 1/20 | 0.67 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.67 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.67 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.67 |
| ▸ | INSR | P06213 | 1/20 | 0.67 |
| ▸ | FYN | P06241 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6460275 | 0.92 | HCK (0.66) | HCKSRCABL1EGFRTEK | |
| SCHEMBL6458140 | 0.92 | HCK (0.66) | HCKSRCABL1EGFRTEK | |
| SCHEMBL6458138 | 0.92 | HCK (0.66) | HCKSRCABL1EGFRTEK | |
| SCHEMBL6465498 | 0.89 | SRC (0.73) | HCKSRCABL1EGFRTEK | |
| SCHEMBL6465500 | 0.89 | SRC (0.73) | HCKSRCABL1EGFRTEK | |
| SCHEMBL23847497 | 0.88 | SRC (0.66) | HCKSRCABL1EGFRTEK | |
| SCHEMBL16752234 | 0.88 | SRC (0.69) | HCKSRCABL1EGFRTEK | |
| SCHEMBL16752236 | 0.88 | SRC (0.69) | HCKSRCABL1EGFRTEK | |
| SCHEMBL6461084 | 0.86 | SRC (0.72) | HCKSRCABL1EGFRTEK | |
| SCHEMBL6460944 | 0.86 | SRC (0.72) | HCKSRCABL1EGFRTEK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050008640-A1 | Method of treating transplant rejection | ABBOTT LABORATORIES | 2005-01-13 | — | — | US | disclosed |
| US-6713474-B2 | SERINE-THREONINE AND TYROSINE KINASE INHIBITORS | ABBOTT GMBH & CO. KG (DE) | 2004-03-30 | — | — | US | disclosed |
| US-20030153752-A1 | Pyrrolopyrimidines as therapeutic agents | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2003-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008640-A1 | Method of treating transplant rejection | LCK, ZAP70, FYN | HCK 107/4885SRC 46/4885ABL1 122/4885 |
| US-20030153752-A1 | Pyrrolopyrimidines as therapeutic agents | FLT1, FLT4, TFPI | HCK 968/4885SRC 206/4885ABL1 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.